On October 17, 2023, the "2023 BioShanghai Biomedical Industry Investment Forum and Future Medical Industry Forum" was held in Minhang Fund Town. With the theme of "Riding the Wind and Waves, Seizing Opportunities", the forum brought together hundreds of investors and industry experts to deeply analyze the policy environment, industry hotspots, and future trends in the biomedical field. At the same time, it connected capital and industry, discussed the industry-finance integration, and contributed wisdom to lead the high-quality development in the biomedical industry.

"2023 China Biomedical Front-Runners 100 List" has been released

This forum unveiled the "2023 China Biomedical Front-Runners 100 List" to introduce the latest status and development trends of the current biomedical industry to the public. The list covers "100 Biomedical Front-Runners", "100 Medical Device Front-Runners" and "100 Digital Healthcare Front-Runners", and selected the Front-Runners of sub-industry tracks.

ConFlow MedTech is listed as the star of medical device growth with its outstanding innovation ability and development speed.

It is reported that the selection focuses on the six dimensions of enterprise strategy, product, competition, business, team, and value, with more than 50 indicators, focusing on industrial capability and ecological guidance, making in-depth research and judgment on enterprises, and finally forming a list. Enterprises are required to have clear and uncontroversial intellectual property rights with no significant records of illegal or dishonest behavior.

A selection system and recommendation system are adopted for list collection, and model scoring and expert review are adopted for enterprise evaluation, to strive for the accuracy and completeness of information and adhere to the principle of fairness and justice.

Ms. Chen Xiumin, the Founder, accepted an exclusive interview with CBN

Ms. Chen Xiumin, founder of ConFlow MedTech, accepted an exclusive interview with CBN, telling the general situation of ConFlow MedTech's development, saying that ConFlow MedTech is dedicated to technological innovation in a down-to-earth manner, and is honored to get industry attention and recognition and get capital support; She outlined the future development strategy, emphasizing clear positioning, optimized integration, focused innovation, and the enhancement of the company's self-generative capacity, aiming to propel the company further and more steadily.

This time, ConFlow MedTech has been listed as a rising star in the medical device industry, which is a full recognition of ConFlow MedTech's scientific research innovation ability, growth ability, and competitiveness by the industry and experts. Since its establishment, ConFlow MedTech has always focused on the innovation and exploration of cutting-edge technologies of structural heart disease, making steady progress on its own feet, striving to be the attacker of cutting-edge technologies and the innovator of leading industries, and making practical efforts will eventually yield results. We believe that the future development of ConFlow MedTech is getting better and better.